paclitaxel has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Jiang, H; Xia, Y; Xu, F; Zhang, D; Zhang, G | 1 |
| Han, WK; Jin, ZH; Lan, Z; Liu, C; Peng, W; Weng, HB; Xiong, YW; Zhang, XM | 1 |
2 other study(ies) available for paclitaxel and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2.
Topics: Animals; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Down-Regulation; Fibrosis; Kidney; Mice; Paclitaxel; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Suppressor Protein p53 | 2023 |
Taxus chinensis ameliorates diabetic nephropathy through down-regulating TGF-β1/Smad pathway.
Topics: Albumins; Animals; Blood Glucose; Creatinine; Diabetic Nephropathies; Drugs, Chinese Herbal; Humans; Kidney; Male; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Taxus; Transforming Growth Factor beta1 | 2018 |